Barinthus Biotherapeutics (BRNS)
NASDAQ: BRNS
· Real-Time Price · USD
1.22
-0.02 (-1.61%)
At close: Aug 18, 2025, 10:57 AM
Barinthus Biotherapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.5 | -0.58 | -1.45 | -0.82 | -1.53 | -2.06 | -2.12 | -0.83 | -1.17 | -1.04 | 3.62 | 2.64 | 18.62 | n/a | -30.09 | -6.56 | -7.86 |
PEG Ratio | 0.13 | -0.00 | 0.03 | -0.11 | 0.14 | -0.1 | 0.05 | -0.03 | 0.08 | 0.00 | -0.08 | 0.01 | n/a | n/a | 0.38 | -0.16 | n/a |
PS Ratio | n/a | -5.19 | 3.13 | n/a | n/a | 26.53 | n/a | 236.89 | 181.94 | 13.71 | 19.33 | 9.70 | 12.88 | n/a | 28.86K | 11.94K | 2.23K |
PB Ratio | 0.34 | 0.37 | 0.29 | 0.36 | 0.55 | 0.76 | 0.61 | 0.36 | 0.36 | 0.36 | 0.49 | 0.65 | 0.77 | n/a | 2.27 | 1.68 | -9.04 |
P/FCF Ratio | -2.63 | 3.72 | -4.1 | -4.57 | -7.84 | -7.32 | -10.61 | -3.96 | -14.99 | -7.42 | 12.58 | -15.85 | -25.21 | n/a | -255.56 | -28.18 | -57.45 |
P/OCF Ratio | -2.63 | 3.59 | -3.38 | -4.64 | -8.04 | -7.27 | -10.64 | -4.67 | -26.83 | -7.81 | 10.03 | -19.73 | -29.4 | n/a | -271.77 | -28.57 | -60.27 |
OCF/S Ratio | n/a | -1.45 | -0.93 | n/a | n/a | -3.65 | n/a | -50.77 | -6.78 | -1.76 | 1.93 | -0.49 | -0.44 | 7.97K | -106.21 | -417.83 | -37.07 |
Debt / Equity Ratio | 0.10 | 0.09 | 0.08 | 0.08 | 0.07 | 0.07 | 0.07 | 0.06 | 0.05 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.01 | -0.03 |
Quick Ratio | 9.18 | 8.03 | 8.93 | 8.46 | 11.15 | 12.45 | 9.21 | 15.26 | 16.74 | 17.40 | 15.58 | 18.60 | 14.00 | 20.32 | 38.60 | 30.05 | 18.89 |
Current Ratio | 9.18 | 8.03 | 8.93 | 8.46 | 11.15 | 12.45 | 9.21 | 15.26 | 16.74 | 17.40 | 15.58 | 18.60 | 14.00 | 20.32 | 38.60 | 30.05 | 18.89 |
Asset Turnover | n/a | -0.06 | 0.08 | n/a | n/a | 0.03 | n/a | 0.00 | 0.00 | 0.02 | 0.02 | 0.06 | 0.05 | -0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage | -1.58K | -1.95K | -551.76 | -1.52K | -1.41K | -2.83K | -2.3K | -1.88K | n/a | -1.17K | n/a | 1.89K | 8.84 | -926 | n/a | n/a | -2.33 |
Return on Equity | -0.17 | -0.16 | -0.05 | -0.11 | -0.09 | -0.09 | -0.07 | -0.11 | -0.08 | -0.09 | 0.03 | 0.06 | 0.01 | -0.06 | -0.02 | -0.06 | 0.29 |
Return on Assets | -0.14 | -0.13 | -0.04 | -0.09 | -0.08 | -0.08 | -0.06 | -0.1 | -0.07 | -0.08 | 0.03 | 0.06 | 0.01 | -0.05 | -0.02 | -0.06 | -0.09 |
Return on Invested Capital | -0.16 | -0.16 | -0.05 | -0.1 | -0.09 | -0.09 | -0.07 | -0.11 | -0.08 | -0.09 | 0.03 | 0.05 | n/a | -0.06 | -0.02 | -0.07 | -0.04 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | -0.32 | 0.91 | n/a | n/a | 0.73 | n/a | -3.85 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Net Profit Margin | n/a | 2.24 | -0.54 | n/a | n/a | -3.22 | n/a | -71.26 | -38.85 | -3.28 | 1.34 | 0.92 | 0.17 | 15.11K | -239.84 | -455.06 | -71.01 |
Pretax Profit Margin | n/a | 2.24 | -0.54 | n/a | n/a | -3.37 | n/a | -74.73 | -40.04 | -3.59 | 1.22 | 0.87 | 0.11 | 15.14K | -240.89 | -456.37 | -71.87 |
Operating Profit Margin | n/a | 2.55 | -0.63 | n/a | n/a | -3.72 | n/a | -78.85 | -45.91 | -4.03 | 1.17 | 0.78 | 0.04 | 16.67K | -291.37 | -481.29 | -28.71 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | 2.09 | -0.44 | n/a | n/a | -3.1 | n/a | -70.8 | -37.43 | -3.27 | 1.40 | 0.92 | 0.18 | 14.8K | -236.42 | -453.4 | -59.11 |